Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dezocine-mediated reversal of sufentanil-induced respiratory depression and its mitigation of adverse reactions: A clinical investigation.

Drug and alcohol dependence·2026
Same author

UGP-RAP: A DI-QDa-MS powered deep learning platform for automated identification of ultrafine granular powders.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Comparative metabolomic profiling and potential bioactive marker discovery of three Clerodendrum species and their different plant parts.

Fitoterapia·2026
Same author

UGP system: A deep learning-driven platform for automated identification of ultrafine granular powders using chromatographic fingerprinting.

Journal of pharmaceutical analysis·2026
Same author

Polypeptide-engineered lipid nanoparticles for mRNA delivery with limited immunogenicity.

Nature communications·2026
Same author

Intercellular Mitochondrial Transfer as Endogenous Neuroprotection: Mechanisms and Therapeutic Implications in Ischemic Stroke.

Translational stroke research·2026

Related Experiment Video

Updated: Jun 9, 2025

Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers
10:36

Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers

Published on: January 24, 2025

378

Engineered bacterium-metal-organic framework biohybrids for boosting radiotherapy with multiple effects.

Jia-Wei Wang1, Ping Ji2, Jin-Yue Zeng2

  • 1Department of Cardiology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, PR China; Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, PR China; Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, PR China.

Biomaterials
|October 24, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces a novel biohybrid platform, SO@Hf-MOF-Pt, for enhancing radiotherapy. It effectively reshapes the tumor microenvironment by metabolizing lactate and generating oxygen, thereby improving therapeutic outcomes.

Keywords:
Biohybrid platformHypoxia microenvironmentLactate metabolismRadiosentizationTumor therapy

More Related Videos

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.1K
Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon
15:28

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon

Published on: November 16, 2012

14.5K

Related Experiment Videos

Last Updated: Jun 9, 2025

Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers
10:36

Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers

Published on: January 24, 2025

378
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.1K
Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon
15:28

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon

Published on: November 16, 2012

14.5K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Therapy

Background:

  • Tumor microenvironments with high hypoxia and lactate levels impede radiotherapy efficacy.
  • Hypoxia-inducible factor (HIF-1α) and lactate dehydrogenase A (LDHA) play critical roles in this suppressive microenvironment.

Purpose of the Study:

  • To develop an engineered biohybrid platform for enhancing radiotherapy by targeting the tumor microenvironment.
  • To investigate the synergistic effects of platinum nanoparticles, hafnium metal-organic frameworks, and Shewanella oneidensis MR-1 in radiosensitization.

Main Methods:

  • Construction of a biohybrid platform (SO@Hf-MOF-Pt) integrating Shewanella oneidensis MR-1 with Hf-MOF-Pt nanoparticles.
  • Utilizing the tumor-targeting and metabolic respiration of SO to downregulate HIF-1α by metabolizing lactate.
  • Leveraging the reaction of SO@Hf-MOF-Pt with hydrogen peroxide to generate oxygen, further inhibiting HIF-1α and LDHA, thus reducing lactate production.

Main Results:

  • The SO@Hf-MOF-Pt platform successfully enriched in tumor sites.
  • Metabolic regulation by SO and nanoparticle-mediated oxygen generation effectively relieved tumor hypoxia and reduced lactate levels.
  • Significant potentiation of radiosensitization and amplification of radiotherapy therapeutic outcomes were observed.

Conclusions:

  • The engineered biohybrid SO@Hf-MOF-Pt platform demonstrates a promising strategy for overcoming the radio-resistant tumor microenvironment.
  • Bacterium-based metabolic regulation offers a novel approach to sensitize radiotherapy and improve cancer treatment.
  • This biohybrid system holds potential for future clinical applications in enhancing radiotherapy effectiveness.